Zimmer Biomet Holdings, Inc. (ZBH)
- Previous Close
121.30 - Open
121.45 - Bid --
- Ask --
- Day's Range
118.62 - 121.45 - 52 Week Range
102.00 - 149.25 - Volume
1,414,603 - Avg. Volume
1,435,709 - Market Cap (intraday)
24.518B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
24.45 - EPS (TTM)
4.88 - Earnings Date May 2, 2024
- Forward Dividend & Yield 0.96 (0.80%)
- Ex-Dividend Date Mar 27, 2024
- 1y Target Est
137.17
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
www.zimmerbiomet.comRecent News: ZBH
Performance Overview: ZBH
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZBH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZBH
Valuation Measures
Market Cap
24.52B
Enterprise Value
30.01B
Trailing P/E
24.45
Forward P/E
14.86
PEG Ratio (5yr expected)
4.49
Price/Sales (ttm)
3.38
Price/Book (mrq)
1.96
Enterprise Value/Revenue
4.06
Enterprise Value/EBITDA
13.52
Financial Highlights
Profitability and Income Statement
Profit Margin
13.85%
Return on Assets (ttm)
4.40%
Return on Equity (ttm)
8.36%
Revenue (ttm)
7.39B
Net Income Avi to Common (ttm)
1.02B
Diluted EPS (ttm)
4.88
Balance Sheet and Cash Flow
Total Cash (mrq)
415.8M
Total Debt/Equity (mrq)
49.71%
Levered Free Cash Flow (ttm)
1.14B
Research Analysis: ZBH
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: ZBH
Analyst Report: Zimmer Biomet Holdings, Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
RatingBullishPrice TargetAnalyst Report: Zimmer Biomet Holdings Inc
Based in Warsaw, Indiana, Zimmer Biomet is the nation's largest pure-play maker of orthopedic devices. The current company arose from the 2015 merger of Zimmer and Biomet, both headquartered in Warsaw, Indiana. The company designs, develops and manufactures reconstructive orthopedic implants; sports injury repair and trauma products; and related orthopedic surgical products. Its primary customers include musculoskeletal surgeons, neurosurgeons, hospitals, distributors, and, in their capacity as agents, healthcare purchasing organizations or buying groups. ZBH shares are a component of the S&P 500.
RatingNeutralPrice TargetMarket Update: ZBH, PSX, PINS
Stocks edged up on Monday ahead of a collection of economic data that will be released this week, including inflation, retail sales and housing data. The Dow rose 0.5%, the S&P 500 was up 0.4%, and the Nasdaq gained 0.5%. Crude oil is trading little changed near $77 per barrel. Gold fell $10 to $2028 per ounce.
Analyst Report: Zimmer Biomet Holdings, Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
RatingBullishPrice Target